Deals
Deals dated after 30 September 2026 are still being collected.
Columns
2 of 2 deals
| Advisers | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 2026 | Theravance Biopharma | – | Zymeworks | Acquisition | Legal and tax adviser to Zymeworks (acquirer) | Pending | 929.0 | Pharma+1 | Lazard (sell-side)Evercore (sell-side)Skadden, Arps, Slate, Meagher & Flom (sell-side)Arthur Cox (sell-side)Kirkland & Ellis (buy-side)MTS Health Partners (buy-side) | Zymeworks acquisition of Theravance Biopharma |
| Jun 2026 | NCS Multistage Holdings | – | Weatherford International | Acquisition | Legal adviser to the issuer | Announced | – | Energy Services+1 | Piper Sandler (sell-side)Baker Botts (sell-side)King & Spalding (buy-side)Weil, Gotshal & Manges (sell-side) | Weatherford International acquisition of NCS Multistage Holdings |